Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 51 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9527884

    Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

    The Board of Regents of the University of Oklahoma · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  2. US 9527841

    Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  3. US 9527878

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  4. US 9526769

    Macrocylic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  5. US 9522910

    Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYOU “FUSION PHARMA” · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  6. US 9518040

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  7. US 9518056

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  8. US 9517230

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  9. US 9513289

    Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases

    The United Sates of America, as Represented by the Department of Veterans Affairs · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  10. US 9512143

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  11. US 9505766

    Kinase inhibitors

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  12. US 9504736

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  13. US 9505719

    Synthesis and use of kinase inhibitors

    VERASTEM, INC. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  14. US 9499487

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  15. US 9498471

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  16. US 9499497

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  17. US 9499495

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  18. US 9487522

    SSH-2 (slingshot-2) inhibitors and methods for making and using them

    The Regents of the University of California · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  19. US 9487514

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  20. US 9486422

    Small molecule inhibitors of Mcl-1 and the uses of thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  21. US 9475822

    Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  22. PT 2481410

    NITROCATECHOL DERIVATES AS COMT INHIBITORS ADMINISTERED WITH A SPECIFIC DOSAGE REGIME

    BIAL-PORTELA & Cª S A [PT] · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  23. US 9468649

    Methods of treating epilepsy with transforming growth factor beta inhibitors

    The Regents of the University of California · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  24. US 9453028

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted